Baynes Roy D., an insider at Natera Inc (NTRA), sold 22,221 shares of the company on November 18, 2025, at a price of $213.47 per share. The total value of the transaction amounted to $4.74 million. Following this sale, Baynes retains 22,221 shares of Natera.
Natera, a biotechnology firm headquartered in Austin, Texas, specializes in genetic testing services. With a market capitalization of $30.7 billion, the company employs 4,424 full-time staff and has developed a range of products, including non-invasive prenatal tests and cancer care assays. The company's earnings per share (EPS) stands at -2.28.
This insider transaction highlights a significant sale, but it is important to understand that such activity can occur for various reasons, including personal financial needs or tax planning. Investors are advised to consider insider transactions as one of many factors in their decision-making process, rather than a definitive indicator of company performance.
Natera's upcoming earnings are projected for May 6, 2026, with an estimated EPS of -0.50 and revenue of $613.6 million, followed by another report on August 5, 2026, with an estimated EPS of -0.54 and revenue of $637.8 million.